Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Chokeberry (Aronia melanocarpa) has been studied for its potential to improve lipid profiles, including the reduction of triglycerides. The scientific rationale behind its use centers on its rich content of polyphenols, especially anthocyanins, which possess antioxidant and anti-inflammatory properties. Several clinical studies support chokeberry’s role in improving cardiovascular risk factors. For example, a randomized controlled trial published in the journal European Journal of Nutrition (2007) involved patients with metabolic syndrome consuming chokeberry extract for two months. The results showed significant reductions in total cholesterol, LDL cholesterol, and triglycerides compared to baseline. Further, a 2010 study in Phytotherapy Research reported similar findings, demonstrating that chokeberry supplementation led to a decrease in triglyceride levels among individuals with mild hypercholesterolemia.

The proposed mechanisms include inhibition of lipid peroxidation, improved endothelial function, and modulation of enzymes involved in lipid metabolism. However, while these results are promising, the body of evidence is still moderate, with limitations such as small sample sizes and short durations. Larger, long-term studies are needed to confirm these effects and determine optimal dosing. At present, the use of chokeberry for reducing high triglycerides is scientifically supported at a moderate level, with evidence suggesting it may be beneficial as an adjunct to lifestyle interventions for cardiovascular risk reduction.

More about chokeberry
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by chokeberry

Products containing chokeberry